Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged?for example, positronemitting radiopharmaceuticals.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceuticals. This report contains market size and forecasts of Nuclear Medicine & Radiopharmaceuticals in global, including the following market information:
- Global Nuclear Medicine & Radiopharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Nuclear Medicine & Radiopharmaceuticals Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Nuclear Medicine & Radiopharmaceuticals companies in 2022 (%)
The global Nuclear Medicine & Radiopharmaceuticals market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The
major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.
We surveyed the Nuclear Medicine & Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine & Radiopharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, by Type, 2022 (%)
Global Nuclear Medicine & Radiopharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, by Application, 2022 (%)
- Oncology
- Thyroid
- Cardiology
- Others
Global Nuclear Medicine & Radiopharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Nuclear Medicine & Radiopharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Nuclear Medicine & Radiopharmaceuticals revenues share in global market, 2022 (%)
- Key companies Nuclear Medicine & Radiopharmaceuticals sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Nuclear Medicine & Radiopharmaceuticals sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- China Isotope & Radiation
- Dongcheng
- Jaco
- Ciaeriar
- Advanced Molecular-imaging Solution
- Shanghai Atom Kexing
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Nuclear Medicine & Radiopharmaceuticals, market overview.
- Chapter 2: Global Nuclear Medicine & Radiopharmaceuticals market size in revenue and volume.
- Chapter 3: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Nuclear Medicine & Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Nuclear Medicine & Radiopharmaceuticals capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nuclear Medicine & Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Medicine & Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nuclear Medicine & Radiopharmaceuticals Overall Market Size
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size: 2022 VS 2029
2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales: 2018-2029
3 Company Landscape
3.1 Top Nuclear Medicine & Radiopharmaceuticals Players in Global Market
3.2 Top Global Nuclear Medicine & Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Companies
3.4 Global Nuclear Medicine & Radiopharmaceuticals Sales by Companies
3.5 Global Nuclear Medicine & Radiopharmaceuticals Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Nuclear Medicine & Radiopharmaceuticals Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Nuclear Medicine & Radiopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Market Size Markets, 2022 & 2029
4.1.2 Diagnostic
4.1.3 Therapeutic
4.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2018-2023
4.2.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2024-2029
4.2.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
4.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2018-2023
4.3.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2024-2029
4.3.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
4.4 By Type - Global Nuclear Medicine & Radiopharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Thyroid
5.1.4 Cardiology
5.1.5 Others
5.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2018-2023
5.2.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2024-2029
5.2.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
5.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2018-2023
5.3.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2024-2029
5.3.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
5.4 By Application - Global Nuclear Medicine & Radiopharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2022 & 2029
6.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2018-2023
6.2.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2024-2029
6.2.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
6.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2018-2023
6.3.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2024-2029
6.3.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, 2018-2029
6.4.2 By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, 2018-2029
6.4.3 US Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.4.4 Canada Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.4.5 Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, 2018-2029
6.5.2 By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, 2018-2029
6.5.3 Germany Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.5.4 France Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.5.5 U.K. Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.5.6 Italy Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.5.7 Russia Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.5.8 Nordic Countries Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.5.9 Benelux Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, 2018-2029
6.6.2 By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, 2018-2029
6.6.3 China Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.6.4 Japan Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.6.5 South Korea Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.6.6 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.6.7 India Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, 2018-2029
6.7.2 By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, 2018-2029
6.7.3 Brazil Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.7.4 Argentina Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, 2018-2029
6.8.3 Turkey Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.8.4 Israel Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.8.5 Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
6.8.6 UAE Nuclear Medicine & Radiopharmaceuticals Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 China Isotope & Radiation
7.1.1 China Isotope & Radiation Company Summary
7.1.2 China Isotope & Radiation Business Overview
7.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.1.5 China Isotope & Radiation Key News & Latest Developments
7.2 Dongcheng
7.2.1 Dongcheng Company Summary
7.2.2 Dongcheng Business Overview
7.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.2.5 Dongcheng Key News & Latest Developments
7.3 Jaco
7.3.1 Jaco Company Summary
7.3.2 Jaco Business Overview
7.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.3.5 Jaco Key News & Latest Developments
7.4 Ciaeriar
7.4.1 Ciaeriar Company Summary
7.4.2 Ciaeriar Business Overview
7.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.4.5 Ciaeriar Key News & Latest Developments
7.5 Advanced Molecular-imaging Solution
7.5.1 Advanced Molecular-imaging Solution Company Summary
7.5.2 Advanced Molecular-imaging Solution Business Overview
7.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.5.5 Advanced Molecular-imaging Solution Key News & Latest Developments
7.6 Shanghai Atom Kexing
7.6.1 Shanghai Atom Kexing Company Summary
7.6.2 Shanghai Atom Kexing Business Overview
7.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.6.5 Shanghai Atom Kexing Key News & Latest Developments
8 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity, Analysis
8.1 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity, 2018-2029
8.2 Nuclear Medicine & Radiopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Nuclear Medicine & Radiopharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nuclear Medicine & Radiopharmaceuticals Supply Chain Analysis
10.1 Nuclear Medicine & Radiopharmaceuticals Industry Value Chain
10.2 Nuclear Medicine & Radiopharmaceuticals Upstream Market
10.3 Nuclear Medicine & Radiopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nuclear Medicine & Radiopharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Nuclear Medicine & Radiopharmaceuticals in Global Market
Table 2. Top Nuclear Medicine & Radiopharmaceuticals Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Companies, 2018-2023
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales by Companies, (K Units), 2018-2023
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Table 9. List of Global Tier 1 Nuclear Medicine & Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2018-2023
Table 15. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2024-2029
Table 16. By Application ? Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2018-2023
Table 20. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2024-2029
Table 21. By Region ? Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2018-2023
Table 25. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2024-2029
Table 26. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2018-2023
Table 29. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2024-2029
Table 30. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2018-2023
Table 33. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2024-2029
Table 34. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2018-2023
Table 37. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2024-2029
Table 38. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2018-2023
Table 41. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2024-2029
Table 46. China Isotope & Radiation Company Summary
Table 47. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 48. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. China Isotope & Radiation Key News & Latest Developments
Table 50. Dongcheng Company Summary
Table 51. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 52. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Dongcheng Key News & Latest Developments
Table 54. Jaco Company Summary
Table 55. Jaco Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 56. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Jaco Key News & Latest Developments
Table 58. Ciaeriar Company Summary
Table 59. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 60. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Ciaeriar Key News & Latest Developments
Table 62. Advanced Molecular-imaging Solution Company Summary
Table 63. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 64. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Advanced Molecular-imaging Solution Key News & Latest Developments
Table 66. Shanghai Atom Kexing Company Summary
Table 67. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 68. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Shanghai Atom Kexing Key News & Latest Developments
Table 70. Nuclear Medicine & Radiopharmaceuticals Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global Nuclear Medicine & Radiopharmaceuticals Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Nuclear Medicine & Radiopharmaceuticals Production by Region, 2018-2023 (K Units)
Table 73. Global Nuclear Medicine & Radiopharmaceuticals Production by Region, 2024-2029 (K Units)
Table 74. Nuclear Medicine & Radiopharmaceuticals Market Opportunities & Trends in Global Market
Table 75. Nuclear Medicine & Radiopharmaceuticals Market Drivers in Global Market
Table 76. Nuclear Medicine & Radiopharmaceuticals Market Restraints in Global Market
Table 77. Nuclear Medicine & Radiopharmaceuticals Raw Materials
Table 78. Nuclear Medicine & Radiopharmaceuticals Raw Materials Suppliers in Global Market
Table 79. Typical Nuclear Medicine & Radiopharmaceuticals Downstream
Table 80. Nuclear Medicine & Radiopharmaceuticals Downstream Clients in Global Market
Table 81. Nuclear Medicine & Radiopharmaceuticals Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nuclear Medicine & Radiopharmaceuticals Segment by Type in 2022
Figure 2. Nuclear Medicine & Radiopharmaceuticals Segment by Application in 2022
Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2018-2029 (US$, Mn)
Figure 7. Nuclear Medicine & Radiopharmaceuticals Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nuclear Medicine & Radiopharmaceuticals Revenue in 2022
Figure 9. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
Figure 11. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
Figure 12. By Type - Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
Figure 15. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
Figure 16. By Application - Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
Figure 20. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
Figure 21. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
Figure 22. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
Figure 23. US Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
Figure 28. Germany Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 29. France Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
Figure 37. China Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 41. India Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
Figure 43. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
Figure 44. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2018-2029
Figure 48. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 52. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Nuclear Medicine & Radiopharmaceuticals by Region, 2022 VS 2029
Figure 54. Nuclear Medicine & Radiopharmaceuticals Industry Value Chain
Figure 55. Marketing Channels
